Bank Negara Indonesia Tbk (BBNI JK) stock market data APIs

Rp4790 0(0%)
as of January 22, 2025

Bank Negara Indonesia Tbk Financial Data Overview

Price chart is built with Anychart

PT Bank Negara Indonesia (Persero) Tbk, together with its subsidiaries, provides various banking products and services in Indonesia, New York, Europe, and Asia. It operates through, Corporate & International Banking, Institutional Banking, Enterprise & commercial Banking, Consumer Banking, Treasury, Head Offices, and Subsidiaries segments. The company offers savings account, savings plan and FIPF, loans, credit cards, simulation services, and others; and business banking, funding, lending, international trade financing, financial institution products, smart remittances, foreign direct investment, treasury products, and Solusi wholesale services, as well as services for micro small and medium enterprises. It also provides e-banking services, that includes ATM, phone banking, SMS notification, SMS banking, mobile banking, mobile services, BNI ipay, BNI Smartpay, BNI Agen46, BNI EDC, BNI debit online, internet payment gateway, open digital savings account, and QRIS, as well as wealth management services. In addition, the company offers life insurance, financing, securities, and venture capital services. PT Bank Negara Indonesia (Persero) Tbk was founded in 1946 and is headquartered in Jakarta Pusat, Indonesia.

Prev. Close 4790
Open 4790
Volume 44 472 K
High 4810
Low 4760
52 wk Range 4110-5975
Market Cap 184 621 635 M
P/E Ratio 8.6111
Shares Outstanding 579 M
Revenue 49 416 543 M
Dividends (Yield) 0.0569
Beta 0.837

Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Bank Negara Indonesia Tbk data using free add-ons & libraries


Get Bank Negara Indonesia Tbk Fundamental Data

Bank Negara Indonesia Tbk Fundamental data includes:

  • Net Revenue: 49 416 543 M
  • EBITDA: 0
  • Earnings Per Share: 574
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Bank Negara Indonesia Tbk Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2025-01-24
  • EPS/Forecast: NaN
GET THE PACKAGE

Get Bank Negara Indonesia Tbk End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Bank Negara Indonesia Tbk News

PT Bank Negara Indonesia (Persero) Tbk (PTBRY) Q3 2024 Earnings Call Highlights: Strong Loan ... New

PT Bank Negara Indonesia (Persero) Tbk (PTBRY) Q3 2024 Earnings Call Highlights: Strong Loan ...

Release Date: October 25, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points PT Bank Negara Indonesia (Persero) Tbk (PTBRY) re...

SSMS Plantation Holdings Pte. Ltd. -- Moody's downgrades Sawit Sumbermas to Caa1; outlook remains negative

SSMS Plantation Holdings Pte. Ltd. -- Moody's downgrades Sawit Sumbermas to Caa1; outlook remains negative

Rating Action: Moody's downgrades Sawit Sumbermas to Caa1; outlook remains negativeGlobal Credit Research - 11 Jan 2022Singapore, January 11, 2022 -- Moody's Investors Service has downgraded the corpo...

Akero Therapeutics Presents Analyses at the 2021 International Liver Congress Showing Normalization of Liver Fat Substantially Reduced Markers of Liver Injury and Fibrosis, and Greatly Increased Probability of Resolving NASH

Akero Therapeutics Presents Analyses at the 2021 International Liver Congress Showing Normalization of Liver Fat Substantially Reduced Markers of Liver Injury and Fibrosis, and Greatly Increased Probability of Resolving NASH

Analyses also Show that Combining a Threshold for ALT Reduction of ≥17 U/L with Normalization of Liver Fat Improves Predictive Power for Resolution of NASH with 1-Stage Improvement of Fibrosis SOUT...

Akero Therapeutics Presents Analyses at the 2021 International Liver Congress Showing Normalization of Liver Fat Substantially Reduced Markers of Liver Injury and Fibrosis, and Greatly Increased Probability of Resolving NASH

Akero Therapeutics Presents Analyses at the 2021 International Liver Congress Showing Normalization of Liver Fat Substantially Reduced Markers of Liver Injury and Fibrosis, and Greatly Increased Probability of Resolving NASH

Analyses also Show that Combining a Threshold for ALT Reduction of ≥17 U/L with Normalization of Liver Fat Improves Predictive Power for Resolution of NASH with 1-Stage Improvement of Fibrosis SOUT...

Get Apple Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat